Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects
Clinical trial NCT04819581 · COMPLETED
Trial details
- NCT number
- NCT04819581
- Sponsor
- Scilex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-03
- Primary completion
- 2019-08-27
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.